Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
4DMedical Ltd ( (AU:4DX) ) has issued an update.
4DMedical Limited has applied to the ASX for quotation of 20,806,185 new fully paid ordinary shares (ASX code: 4DX), with an issue date of 22 January 2026. The move will expand the company’s quoted share base and may provide additional liquidity for investors, marking another capital markets step that supports the company’s ongoing operational and growth activities in the medical imaging and respiratory diagnostics sector.
The most recent analyst rating on (AU:4DX) stock is a Sell with a A$3.20 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Limited (ASX: 4DX) is an Australian-listed medical technology company focused on lung imaging and respiratory diagnostics. The company develops and commercialises software and imaging solutions that quantify lung function from existing medical imaging modalities, targeting hospitals, clinics and research institutions involved in respiratory care and pulmonary disease management.
Average Trading Volume: 4,937,112
Technical Sentiment Signal: Buy
Current Market Cap: A$2.75B
Learn more about 4DX stock on TipRanks’ Stock Analysis page.